About Us

Our Company

Neurocrine Biosciences, Inc of San Diego is a product based biopharmaceutical company focusing on the development and commercialization of innovative pharmaceutical products to treat unmet medical needs.

The Company's research and development efforts are focused on neurological and endocrine diseases and disorders.  Our product candidates address some of the largest pharmaceutical markets in the world including endometriosis, stress-related disorders, pain, diabetes, insomnia, and other neurological and endocrine-related diseases and disorders.

Research and Development Programs

Neurocrine’s Research Group continues to advance novel small molecule compounds into clinical development. Neurocrine scientists are focusing on developing small molecule antagonists against G-protein coupled receptors. Our scientists possess the skills and experience necessary to bring compounds from basic research concepts to drug candidate stage. Neurocrine utilizes advanced technologies to enhance its drug discovery capabilities and to accelerate the drug development process. Working together, Neurocrine's chemists, pharmacologists and biologists strive to create new solutions to unmet medical problems.

Neurocrine Biosciences Corporate Information

The Company’s common stock is traded on the Nasdaq Global Select Market System under the symbol “NBIX”

Contact Information